HDAC-IN-42

Modify Date: 2024-01-10 23:04:42

HDAC-IN-42 structure	Common Name	HDAC-IN-42
	CAS Number	2454024-18-9	Molecular Weight	381.34
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₀H₁₅NO₇	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of HDAC-IN-42

HDAC-IN-42 (compound 14f) is a potent and selective HDAC inhibitor with IC50 values of 0.19 and 4.98 µM for HDAC1 and HDAC6, respectively. HDAC-IN-42 shows anticancer and anti-proliferative activity. HDAC-IN-42 induces apoptosis and cell cycle arrest at G2/M phase[1].

Name	HDAC-IN-42

Description	HDAC-IN-42 (compound 14f) is a potent and selective HDAC inhibitor with IC50 values of 0.19 and 4.98 µM for HDAC1 and HDAC6, respectively. HDAC-IN-42 shows anticancer and anti-proliferative activity. HDAC-IN-42 induces apoptosis and cell cycle arrest at G2/M phase[1].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> HDAC Signaling Pathways >> Epigenetics >> HDAC
Target	HDAC1:0.19 μM (IC50) HDAC6:4.98 μM (IC50)
In Vitro	HDAC-IN-42 (compound 14f) shows anti-proliferative activity with C50s of 9.56, 13.32, 10.46, 6.91 µM for MCF-7, HCT-116, HepG2, Hela cells, respectively[1]. HDAC-IN-42 (1, 5, 10 µM; 24 h) reduces the colony formation and increases the expression of histone H3 and α-tubulin in HeLa cells[1]. HDAC-IN-42 (1, 5, 10 µM; 48 h) induces apoptosis and cell cycle arrest at G2/M phase[1].
References	[1]. Ding J, et al. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities. Bioorg Chem. 2020 Aug;101:104023.

Molecular Formula	C₂₀H₁₅NO₇
Molecular Weight	381.34

HDAC-IN-42

Use of HDAC-IN-42

Names

HDAC-IN-42 Biological Activity

Chemical & Physical Properties